Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of experimental therapeutics and oncology

• Publication date

  2011-12-29

• Fields of study

  Medicine

• Identifiers
  PMID 22070050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

  2009cited by this paper
• Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV

  2008cited by this paper
• Expression of galectin-3, cytokeratin 19, neural cell adhesion molecule and E-cadhedrin in certain variants of papillary thyroid carcinoma.

  2008cited by this paper
• Thyroid cancer: are molecular studies making any difference?

  2007cited by this paper
• RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy.

  2007cited by this paper
• Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27kip1 in the Differential Diagnosis of Thyroid Nodules

  2007cited by this paper
• Significance of VEGF and NF-kB expression in thyroid carcinoma

  2006cited by this paper
• Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.

  2006cited by this paper
• Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining

  2006cited by this paper
• Prognostic value of E-cadherin expression in thyroid follicular carcinoma.

  2005cited by this paper
• Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

  2005cited by this paper
• Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788

  2005cited by this paper
• Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential

  2005cited by this paper
• Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancy

  2005cited by this paper
• Oncogenic and Anti-apoptotic Activity of NF-κB in Human Thyroid Carcinomas*

  2004cited by this paper
• β-Catenin expression in thyroid follicular lesions: Potential role in nuclear envelope changes in papillary carcinomas

  2004cited by this paper
• E‐cadherin loss rather than β‐catenin alterations is a common feature of poorly differentiated thyroid carcinomas

  2003cited by this paper
• Changes in Galectin-7 and Cytokeratin-19 Expression during the Progression of Malignancy in Thyroid Tumors: Diagnostic and Biological Implications

  2002cited by this paper
• Immunohistochemical detection of E-cadherin, α- and β-catenins in papillary thyroid carcinoma

  2002cited by this paper
• Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma

  2001cited by this paper
• Clinical significance of E‐cadherin expression in thyroid neoplasms

  2001cited by this paper
• β-Catenin Dysregulation in Thyroid Neoplasms : Down-Regulation, Aberrant Nuclear Expression, and CTNNB1 Exon 3 Mutations Are Markers for Aggressive Tumor Phenotypes and Poor Prognosis

  2001cited by this paper
• Integrins in thyroid tissue: upregulation of alpha2beta1 in anaplastic thyroid carcinoma.

  1998cited by this paper
• The tumor-suppressor function of E-cadherin.

  1998cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome.

  1997cited by this paper
• The E-cadherin/catenin complex in invasion and metastasis.

  1996cited by this paper
• Cadherin‐catenin complex: Protein interactions and their implications for cadherin function

  1996cited by this paper
• Follicular lesions of the thyroid. Does frozen section evaluation alter operative management?

  1995cited by this paper

• The Relationship Between PDE4 and AQP5 in Lung Tissue Under Inflammatory Conditions: An Experimental Study.

  2025cites this paper
• Mesenchymal stem cells preconditioned with a TLR5 agonist enhanced immunoregulatory effect through M2 macrophage polarization in a murine graft-versus-host disease model

  2024cites this paper
• Artemisia annua L. Polyphenols Enhance the Anticancer Effect of β-Lapachone in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells

  2023cites this paper
• Immunocytochemistry in thyroid cytology and its multiple roles: a systematic review

  2023cites this paper
• Expression of β-Catenin in Thyroid Neoplasms (Histopathological and Immunohistochemical Study)

  2022influential citation
• Diagnostic value of beta-catenin immunohistochemical staining in papillary thyroid carcinoma

  2021influential citation
• Diagnostic and prognostic impact of Cytokeratin 19 expression analysis in human tumors: A tissue microarray study of 13,172 tumors.

  2021cites this paper
• NF-κB–Activated miR-574 Promotes Multiple Malignant and Metastatic Phenotypes by Targeting BNIP3 in Thyroid Carcinoma

  2020cites this paper
• E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer

  2019influential citation
• eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy

  2019cites this paper
• Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

  2019cites this paper
• Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma.

  2018cites this paper
• Immunohistochemical Evaluation of β-Catenin Marker in Papillary Thyroid Cancer: Clinicopathologic Significance

  2018cites this paper
• Application of CK 19 and CD 56 Immunohistochemical Markers in the Diagnosis of Thyroid Tumors

  2018cites this paper
• The importance of selected cell adhesion molecules in thyroid cancer

  2018cites this paper
• High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.

  2018cites this paper
• APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions

  2017cites this paper
• Molecular Targeted Therapies of Aggressive Thyroid Cancer

  2015cites this paper
• Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer

  2015cites this paper
• Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.

  2015cites this paper
• New Therapies for Dedifferentiated Papillary Thyroid Cancer

  2015cites this paper
• Well-Differentiated Follicular Patterned Tumors of the Thyroid With High-Grade Features Can Metastasize in the Absence of Capsular or Vascular Invasion

  2014cites this paper
• Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.

  2014cites this paper
• UNIVERSIDADE FEDERAL DA PARAÍBA CENTRO DE CIÊNCIAS EXATAS E DA NATUREZA PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR

  2014cites this paper
• Expression Levels and Significance of Nuclear Factor-κB and Epidermal Growth Factor Receptor in Hepatolithiasis Associated with Intrahepatic Cholangiocarcinoma

  2013cites this paper
• Effect of Wnt/β-catenin and NF-κB signaling pathways on mucus secretion with hypertonicity in 16HBE cells

  2013cites this paper
• Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior

  2013cites this paper
• Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development

  2013cites this paper
• Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.

  2013cites this paper
• Evaluation of Expression and Function of VEGFR 2 , PDGFRα , PDGFRβ , KIT

  2012influential citation
• Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma

  2012influential citation